ARK Genomic Revolution ETF (ARKG)

Key Metrics

TER 75.00% per year

Distribution policy Accumulating

Fund size USD 1,273 M

Inception date October 31, 2014

Holdings 35

Fund currency USD

Fund domicile US

Provider ARK

For full official fund details, factsheets, and holdings, visit ark-funds.com (opens in new tab).

Historical Return

Last updated: Jun 15, 2026

1 Year +39.9%

3 Years (avg.) -1.7%

5 Years (avg.) -17.1%

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

39.70% 1 Year

41.79% 3 Years

44.96% 5 Years

40.89% 10 Years

Max Drawdown

-27.51% 1 Year

-51.96% 3 Years

-80.30% 5 Years

-83.69% 10 Years

Sharpe Ratio

0.85 1 Year

0.07 3 Years

-0.28 5 Years

0.26 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026

	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2014	5.6%	2.0%	-4.4%	5.6%	3.3%	8.3%	24.0%	14.5%	3.1%	4.6%	1.1%	2.5%
2015		-1.6%	-9.0%	5.6%	2.7%	8.8%	27.3%	15.9%	2.8%	4.5%	0.7%	2.2%
2016			-15.9%	9.5%	4.2%	11.5%	34.1%	19.0%	3.5%	5.3%	0.9%	2.6%
2017				42.5%	16.0%	22.6%	50.6%	27.6%	7.1%	8.7%	3.3%	4.8%
2018					-5.5%	13.7%	53.5%	24.2%	1.2%	3.9%	-1.4%	0.9%
2019						36.7%	95.5%	36.0%	2.9%	5.9%	-0.7%	1.8%
2020							179.6%	35.6%	-6.4%	-0.6%	-6.8%	-3.0%
2021								-34.2%	-45.8%	-29.6%	-29.2%	-21.5%
2022									-55.4%	-27.2%	-27.5%	-18.0%
2023										18.8%	-7.5%	0.4%
2024											-28.0%	-7.7%
2025												18.4%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%

85%

1y 3y N/A N/A

0 - 5%

1y 3y N/A N/A

5 - 10%

1y 3y N/A N/A

10 - 15%

1y 3y N/A N/A

15 - 20%

1y 3y N/A N/A

20 - 30%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

89%

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

1y 3y N/A N/A

15 - 20

1y 3y N/A N/A

20 - 25

1y 3y N/A N/A

25 - 35

1y 3y N/A N/A

35 - 50

1y 3y N/A N/A

> 50

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

2.5%

1y 3y N/A N/A

Small Cap

33.7%

1y 3y N/A N/A

Mid Cap

40.8%

1y 3y N/A N/A

Large Cap

23.0%

1y 3y N/A N/A

Mega Cap

0.0%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$10.2B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	0.03%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	1.95	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	30.96	28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-42.66	-
Profitable Companies	11%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	17.96	14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	10.17	8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	4.04	10.72

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	-30.72	21.15
Enterprise Value to Revenue Enterprise value divided by revenue	10.88	8.72
Total Debt to Enterprise Value Total debt divided by enterprise value	0.12	0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	0.03	0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	-20.07%	-6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+10.4%	-117.9%
Return on Equity Equity divided by market cap.	-13.30%	1.23%
Return on Assets Indicates a company's profitability in relation to its total assets.	-16.84%	3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	-20.45%	3.31%

Sectors

Manufacturing	46.4%
Professional, Scientific, and Technical Services	23.6%
Health Care and Social Assistance	17.1%
Healthcare	1.9%
Real Estate and Rental and Leasing	0.7%
Other	10.2%

Countries

United States	85.6%
Switzerland	7.5%
Other	3.2%
United Kingdom	2.9%
Germany	0.8%
Other	0.0%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Tempus AI Inc. - Ordinary Shares - Class A

TEM

Market Cap $8.87B

P/E Ratio -30.0

Dividends 0.0%

Total Investment $105.01M

Weight 8.25%

Loading details…

CRISPR Therapeutics AG

CRSP - Manufacturing

Market Cap $5.22B

P/E Ratio -8.7

Dividends 0.0%

Total Investment $101.65M

Weight 7.99%

Loading details…

Twist Bioscience Corp

TWST - Professional, Scientific, and Technical Services

Market Cap $5.45B

P/E Ratio -66.5

Dividends 0.0%

Total Investment $91.55M

Weight 7.19%

Loading details…

Personalis Inc

PSNL - Health Care and Social Assistance

Market Cap $936M

P/E Ratio -11.5

Dividends 0.0%

Total Investment $78.04M

Weight 6.13%

Loading details…

Guardant Health Inc

GH - Manufacturing

Market Cap $17.47B

P/E Ratio -38.9

Dividends 0.0%

Total Investment $76.12M

Weight 5.98%

Loading details…

10x Genomics Inc - Ordinary Shares - Class A

TXG - Professional, Scientific, and Technical Services

Market Cap $4.41B

P/E Ratio -196.8

Dividends 0.0%

Total Investment $66.42M

Weight 5.22%

Loading details…

Beam Therapeutics Inc

BEAM - Manufacturing

Market Cap $3.51B

P/E Ratio -53.3

Dividends 0.0%

Total Investment $61.03M

Weight 4.79%

Loading details…

Illumina Inc

ILMN - Manufacturing

Market Cap $24.5B

P/E Ratio 29.0

Dividends 0.0%

Total Investment $57.56M

Weight 4.52%

Loading details…

Natera Inc

NTRA - Health Care and Social Assistance

Market Cap $33.14B

P/E Ratio -144.7

Dividends 0.0%

Total Investment $54.67M

Weight 4.30%

Loading details…

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

RXRX - Professional, Scientific, and Technical Services

Market Cap $1.44B

P/E Ratio -3.1

Dividends 0.0%

Total Investment $50.92M

Weight 4.00%

Loading details…

Caredx Inc

CDNA - Health Care and Social Assistance

Market Cap $1.35B

P/E Ratio -165.6

Dividends 0.0%

Total Investment $43.7M

Weight 3.43%

Loading details…

Veracyte Inc

VCYT - Health Care and Social Assistance

Market Cap $4.28B

P/E Ratio 48.5

Dividends 0.0%

Total Investment $41.79M

Weight 3.28%

Loading details…

Adaptive Biotechnologies Corp

ADPT - Manufacturing

Market Cap $2.81B

P/E Ratio -53.5

Dividends 0.0%

Total Investment $39.76M

Weight 3.12%

Loading details…

Intellia Therapeutics Inc

NTLA - Manufacturing

Market Cap $1.76B

P/E Ratio -4.7

Dividends 0.0%

Total Investment $39.39M

Weight 3.09%

Loading details…

Absci Corp

ABSI - Professional, Scientific, and Technical Services

Market Cap $1.16B

P/E Ratio -8.9

Dividends 0.0%

Total Investment $35.94M

Weight 2.82%

Loading details…

Ionis Pharmaceuticals Inc

IONS - Manufacturing

Market Cap $12.25B

P/E Ratio -37.4

Dividends 0.0%

Total Investment $33.25M

Weight 2.61%

Loading details…

Schrodinger Inc

SDGR - Manufacturing

Market Cap $1.18B

P/E Ratio -11.3

Dividends 0.0%

Total Investment $29.6M

Weight 2.33%

Loading details…

Nurix Therapeutics Inc

NRIX - Manufacturing

Market Cap $1.52B

P/E Ratio -6.5

Dividends 0.0%

Total Investment $26.3M

Weight 2.07%

Loading details…

Pacific Biosciences of California Inc

PACB - Manufacturing

Market Cap $434.84M

P/E Ratio -3.3

Dividends 0.0%

Total Investment $25.18M

Weight 1.98%

Loading details…

Butterfly Network Inc - Ordinary Shares - Class A

BFLY - Healthcare

Market Cap $2.33B

P/E Ratio -30.2

Dividends 0.0%

Total Investment $24.67M

Weight 1.94%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) Over Potential Securities Fraud Allegations

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM

Average metrics of all companies in portfolio

Sectors

Countries